During the forecast period 2023 to 2033, the global atrophic vaginitis treatment industry size is expected to grow at a value of 8% CAGR, according to Future Market Insights. The market is likely to reach US$ 2.78 Billion in 2023, By the year 2033, the global market for Atrophic vaginitis treatment is expected to rise …
Monthly Archives: December 2023
Global Treatment-Resistant Hypertension Management Industry is anticipated to reach US$ 159.41 Million by 2033, is a Promising Indicator for Improved Patient Outcomes | FMI
The global treatment-resistant hypertension management industry growth is projected to grow at a CAGR of 14% between 2023 and 2033, from US$ 43 million in 2023 to US$ 159.41 million by 2033. The market for controlling hypertension that is resistant to therapy grew at a CAGR of 11% from 2018 to 2022. The global treatment-resistant …
Global Neovascular Age-related Macular Degeneration Treatment Industry is projected to attain a 5% CAGR by 2033, as per an FMI report
According to a new market research report published by Future Market insights, the global neovascular age-related macular degeneration treatment industry size is expected to grow at a CAGR of 5% from 2023 to 2033, The global neovascular age-related macular degeneration treatment market is expected to garner a market value of US$ 3 billion in 2023, and reaching a market size …
Corrugated Bubble Wrap Market Growing at 10% of Huge CAGR by 2031: In Depth Research Report by FMI
Corrugated bubble wrap represents a potential advancement in packaging materials, combining the protective qualities of traditional bubble wrap with the structural integrity of corrugated materials. This type of packaging innovation is designed to provide enhanced protection for fragile items during shipping and handling. The packaging industry is constantly evolving to meet the demands of various …
Global Crohn’s Disease (CD) Treatment Industry is on target to reach US$ 17.80 Billion by 2033, as reported in the FMI study
By the end of 2023, the global crohn’s disease (CD) treatment industry size is expected to be worth US$ 11.68 billion. According to Future Market Insights, the market is expected to grow at a 4.3% CAGR from 2023 to 2033, with a market worth approximately US$ 17.80 billion by the end of 2033. The incidence …
Global AL Amyloidosis Therapeutics Industry is expected to experience significant expansion, aiming for a value of US$ 4.56 Billion by 2033, according to FMI
The global AL amyloidosis therapeutics industry size is expected to be worth US$ 2.25 billion by the year of 2023. The market, which is estimated to be worth US$ 4.56 billion by 2033, will grow at a 7.3% CAGR, according to the market intelligence firm, Future Market Insights. AL amyloidosis is an uncommon illness characterized …
Europe Extended Stay Hotel Market Poised for Comfort-Driven Surge, Projecting a Noteworthy 11.8% CAGR, Reaching US$ 166.58 Billion by 2033 | FMI
The extended stay hotel market is set to experience significant expansion in the coming years, displaying a promising growth trajectory. Projections indicate that by 2023, the market is expected to reach a notable value of US$ 54.51 billion, showcasing its strong growth potential. This positive momentum is projected to continue as the market steadily progresses at a rate …
Point-of-Care Opioid Testing Market Accelerates, Targeting Exceedance of US$ 725.1 Million by 2033-FMI Study
The point-of-care opioid testing market is anticipated to reach a valuation of US$ 450.9 million by 2023. The market is anticipated to grow at a 4.9% CAGR over the course of the forecast period, reaching US$ 725.1 million by 2033. The growing opioid epidemic, growing public awareness of drug abuse, and the demand for effective testing techniques …
Global Molluscum Contagiosum (MC) Treatment Industry is projected to maintain a 5% CAGR till 2033, based on FMI’s evaluation
The global molluscum contagiosum (MC) treatment industry size is expected to grow significantly from 2018 to 2022, with a continued upward trajectory in demand from 2023 to 2033. Factors such as increasing prevalence of MC, growing awareness and diagnosis rates, availability of advanced treatment options, and high healthcare expenditure are expected to drive market growth …
Polymyxin Resistance Testing Market Advances Toward US$ 222.5 Million by 2033-FMI Study
In 2023, the polymyxin resistance testing market size is projected to be worth US$ 122.0 million. The market is projected to expand at a 6.2% CAGR during the forecast period, reaching US$ 222.5 million by 2033. Serious infections caused by Gram-negative bacteria that are resistant to several medications, including those that are resistant to other …